Master Class.

On 11th September there was an EMA webinar to launch the updates to GVP Module XVI on Risk Minimisation Measures and its Addendum II. Read on for a summary of the key updates…

The Risk Management Plan (RMP) is a detailed description of the activities and interventions designed to identify, characterise, prevent or minimise risks relating to medicines. Read on to find out how this important document differs across the world.

August was National Immunisation Awareness Month. To highlight the importance of getting vaccinated, Pharmora has prepared a Masterclass series, discussing types of vaccines, why we need them, and the health implications of getting a jab. Read this first blog to understand the current vaccination scheme in the UK, and boost your general knowledge on immunisation!

To celebrate the anniversary of the finalisation of the HGR Implementation Rules in China, we have published a series of blogs, covering the basis, history, recent changes and importance of HGR.

In this final blog of the series, we will describe the different types of licencing and explain how to save time navigating the steps involved in applying for an administrative licence for international clinical trials. Read on to learn more…

To celebrate the first anniversary of finalisation of the HGR regulations we are exploring this important regulation and how it impacts on our work.

Part two of this HGR series explains how to identify which samples could fall under this regulation, how to determine whether you are defined as a “Foreign party” and describes the recent changes to the regulatory structure overseeing HGR. Read on to learn more…

To celebrate the anniversary of finalisation of this important regulation, we have created a series of blogs, exploring the HGR regulation in China, recent changes and how it impacts our work in clinical development. Read the first in our HGR series to find out more…